Background: Lipid transfer proteins (LTPs) are relevant fruit allergens, recently proposed as model plant food allergens. No citrus fruit allergen has been characterized to date. We sought to identify and isolate citrus fruit LTPs and to explore their relevance in orange allergy. Methods: Twenty-seven patients, showing mainly oral allergy syndrome after orange ingestion, as well as positive prick responses and serum-specific IgE levels to orange, were selected. Natural orange and lemon LTPs, as well as a recombinant orange LTP isoform expressed in Pichia pastoris, were isolated by chromatographic methods and characterized by N-terminal amino acid sequencing and matrix-assisted laser desorption/ionizaion mass spectrometry, and DNA sequencing of the corresponding cDNA in the case of the recombinant allergen. Specific IgE determination, immunodetection, ELISA-inhibition assays and in vivo skin prick tests (SPTs) were performed with all three purified allergens and with the major peach LTP allergen, Pru p 3. Results: The natural allergens purified from orange (nCit s 3) and lemon (nCit l 3) showed very similar N-terminal amino acid sequences (18 out of 20 identical residues), typical of LTPs, and molecular masses of 9,610 and 9,618 Da, respectively. The recombinant orange isoform (rCit s 3) expressed in P. pastoris (16 out of 20 residues identical to its natural counterpart in the N-terminal region) presented 92 amino acid residues and 9,463 Da, and 67% sequence identity with rPru p 3. Of the 27 sera analyzed, specific IgE to the purified allergens was found in 54% for nCit l 3, 48% for nCit s 3, 46% for rCit s 3 and 37% for rPru p 3. Positive SPT responses were obtained in 7 out of 26 patients tested for nCit s 3, 3 out of 8 for nCit l 3 and 10 out of 26 for nPru p 3. ELISA-inhibition assays showed an equivalent IgE-binding pattern for the natural and recombinant orange LTPs, and IgE cross-reactivity among the purified orange, lemon and peach LTP allergens. Conclusions: Members of the LTP allergen family are involved in allergy to oranges, displaying positive in vitro and in vivo reactions in 30–50% of the patients studied. Both orange and lemon allergens show cross-reactivity with the major peach allergen Pru p 3.

1.
Saarinen UM, Kajosaari M: Does dietary elimination in infancy prevent or only postpone a food allergy? A study of fish and citrus allergy in 375 children. Lancet 1980;i:166–167.
2.
Zhu SL, Ye ST, Yu Y: Allergenicity of orange juice and orange seeds: A clinical study. Asian Pac J Allergy Immunol 1989;7:5–8.
3.
Cardullo AC, Ruszkowski AM, DeLeo VA: Allergic contact dermatitis resulting from sensitivity to citrus peel, geraniol, and citral. J Am Acad Dermatol 1989;21:395–397.
4.
Sen D, Wiley K, Williams JG: Occupational asthma in fruit salad processing. Clin Exp Allergy 1998;28:363–367.
5.
Kim YK, Son JW, Kim HY, Park HS, Lee MH, Cho SH, Min KU, Kim YY: New occupational allergen in citrus farmers: Citrus red mite (Panonychus citri). Ann Allergy Asthma Immunol 1999;82:223–228.
6.
Brockow K, Hautmann C, Fotisch K, Rakoski J, Borelli S, Vieths S, Ring J: Orange-induced skin lesions in patients with atopic eczema: Evidence for a non-IgE-mediated mechanism. Acta Derm Venereol 2003;83:44–48.
7.
Ibañez MD, Sastre J, San Ireneo MM, Laso MT, Barber D, Lombardero M: Different patterns of allergen recognition in children allergic to orange. J Allergy Clin Immunol 2004;113:175–177.
8.
Kader JC: Lipid-transfer proteins in plants. Annu Rev Plant Physiol Plant Mol Biol 1996;47:627–654.
9.
Van Ree R: Clinical importance of non-specific lipid transfer proteins as food allergens. Biochem Soc Trans 2002;30:910–913.
10.
Salcedo G, Sanchez-Monge R, Diaz-Perales A, Garcia-Casado G, Barber D: Plant non-specific lipid transfer proteins as food and pollen allergens. Clin Exp Allergy 2004;34:1336–1341.
11.
Asero R, Mistrello G, Roncarolo D, de Vries SC, Gautier MF, Ciurana CLF, Verbeek E, Mohammadi T, Knul-Brettlova V, Akkerdaas JH, Bulder I, Aalberse RC, van Ree R: Lipid transfer protein: A pan-allergen in plant-derived foods that is highly resistant to pepsin digestion. Int Arch Allergy Immunol 2000;122:20–32.
12.
Fernandez-Rivas M, Gonzalez-Mancebo E, Rodriguez-Perez R, Benito C, Sanchez-Monge R, Salcedo G, Alonso MD, Rosado A, Tejedor MA, Vila C, Casas ML: Clinically relevant peach allergy is related to peach lipid transfer protein, Pru p 3, in the Spanish population. J Allergy Clin Immunol 2003;112:789–795.
13.
Garcia-Selles FJ, Diaz-Perales A, Sanchez-Monge R, Alcantara M, Lombardero M, Barber D, Salcedo G, Fernandez-Rivas M: Patterns of reactivity to lipid transfer proteins of plant foods and Artemisia pollen: An in vivo study. Int Arch Allergy Immunol 2002;128:115–122.
14.
Asero R, Mistrello G, Roncarolo D, Amato S, Caldironi G, Barocci F, van Ree R: Immunological cross-reactivity between lipid transfer proteins from botanically unrelated plant-derived foods: A clinical study. Allergy 2002;57:900–906.
15.
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
16.
Diaz-Perales A, Garcia-Casado G, Sanchez-Monge R, Garcia-Selles FJ, Barber D, Salcedo G: cDNA cloning and heterologous expression of the major allergens from peach and apple belonging to the lipid-transfer protein family. Clin Exp Allergy 2002;32:87–92.
17.
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–685.
18.
Chang S, Puryear J, Cairney J: A simple and efficient method for isolating RNA from pine trees. Plant Mol Biol Rep 1993;11:113–116.
19.
Wu Z, Burns JK: Isolation and characterization of a cDNA encoding a lipid transfer protein expressed in ‘Valencia’ orange during abscission. J Exp Bot 2003;54:1183–1191.
20.
Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Nat Acad Sci USA 1974;76:4350–4354.
21.
Sanchez-Madrid F, Morago G, Corbi AL, Carreira J: Monoclonal antibodies to three distinct epitopes on human IgE: Their use for determination of allergen-specific IgE. J Immunol Methods 1984;73:367–378.
22.
Diaz-Perales A, Sanz ML, Garcia-Casado G, Sanchez-Monge R, Garcia-Selles FJ, Lombardero M, Polo F, Gamboa PM, Barber D, Salcedo G: Recombinant Pru p 3 and natural Pru p 3, a major peach allergen, show equivalent immunologic reactivity: A new tool for the diagnosis of fruit allergy. J Allergy Clin Immunol 2003;111:628–633.
23.
Malling HJ: Methods of skin testing. Allergy 1993;48(suppl):55–56.
24.
Garcia-Casado G, Pacios LF, Diaz-Perales A, Sanchez-Monge R, Lombardero M, Garcia-Selles FJ, Polo F, Barber D, Salcedo G: Identification of IgE-binding epitopes of the major peach allergen Pru p 3. J Allergy Clin Immunol 2003;112:599–605.
25.
Fernandez-Rivas M, Cuevas M: Peels of Rosaceaefruits have a higher allergenicity than pulps. Clin Exp Allergy 1999;29:1239–1247.
26.
Rodriguez-Perez R, Crespo JF, Rodriguez J, Salcedo G: Profilin is a relevant melon allergen susceptible to pepsin digestion in patients with oral allergy syndrome. J Allergy Clin Immunol 2003;111:634–639.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.